Trending

Clovis Oncology

Tesaro stock rockets as rumours of Roche takeover abound

Tesaro stock rockets as rumours of Roche takeover abound

Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.

X

Tesaro stock rockets as rumours of Roche takeover abound

https://pharmaphorum.com/news/tesaro-stock-rockets-roche-takeover-abound/

Clovis’ PARP drug gets new US ovarian cancer use

Clovis’ PARP drug gets new US ovarian cancer use

Rucaparib gets FDA OK in maintenance use

X

Clovis’ PARP drug gets new US ovarian cancer use

https://pharmaphorum.com/news/clovis-parp-drug-gets-new-us-ovarian-cancer-use/

Clovis’ Rubraca close to EU approval in ovarian cancer

Clovis’ Rubraca close to EU approval in ovarian cancer

CHMP backs conditional approval for PARP drug

X

Clovis’ Rubraca close to EU approval in ovarian cancer

https://pharmaphorum.com/oncology/clovis-rubraca-close-eu-approval-ovarian-cancer/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com